PLK1-IN-13, CAS [[3038489-48-1]] Preis auf Anfrage

Artikelnummer: TGM-T206596
Artikelname: PLK1-IN-13, CAS [[3038489-48-1]] Preis auf Anfrage
Artikelnummer: TGM-T206596
Hersteller Artikelnummer: T206596
Alternativnummer: TGM-T206596-10MG,TGM-T206596-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
PLK1-IN-13 is a selective, orally active PLK1 inhibitor with an IC50 of 0.27 nM. It also inhibits PLK2 (IC50: 12.72 nM) and PLK3 (IC50: 4.12 nM). PLK1-IN-13 induces cell cycle arrest at the G2 phase, promotes apoptosis, and downregulates the transcription of the cancer-associated oncogene c-MYC. This compound inhibits tumor growth and is applicable for research in acute myeloid leukemia (AML).
Molekulargewicht: 577.744
CAS Nummer: [3038489-48-1]
Formel: C29H39N9O2S
Target-Kategorie: PLK|||Apoptosis|||c-Myc
T206596